β-Amyloid Activates the Mitogen-Activated Protein Kinase Cascade via Hippocampal α7 Nicotinic Acetylcholine Receptors:In VitroandIn VivoMechanisms Related to Alzheimer's Disease

Journal of Neuroscience - Tập 21 Số 12 - Trang 4125-4133 - 2001
Kelly T. Dineley1, Marcus A. Westerman2, Duy Bui1, Karen A. Bell1, Karen H. Ashe3,2, J. David Sweatt1
1Division of Neuroscience, Baylor College of Medicine, Houston, Texas 77030, and Departments of
2Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455
3Neurology and,

Tóm tắt

Alzheimer's Disease (AD) is the most common of the senile dementias, the prevalence of which is increasing rapidly, with a projected 14 million affected worldwide by 2025. The signal transduction mechanisms that underlie the learning and memory derangements in AD are poorly understood. β-Amyloid (Aβ) peptides are elevated in brain tissue of AD patients and are the principal component of amyloid plaques, a major criterion for postmortem diagnosis of the disease. Using acute and organotypic hippocampal slice preparations, we demonstrate that Aβ peptide 1-42 (Aβ42) couples to the mitogen-activated protein kinase (MAPK) cascade via α7 nicotinic acetylcholine receptors (nAChRs).In vivoelevation of Aβ, such as that exhibited in an animal model for AD, leads to the upregulation of α7 nAChR protein. α7 nAChR upregulation occurs concomitantly with the downregulation of the 42 kDa isoform of extracellular signal-regulated kinase (ERK2) MAPK in hippocampi of aged animals. The phosphorylation state of a transcriptional mediator of long-term potentiation and a downstream target of the ERK MAPK cascade, the cAMP-regulatory element binding (CREB) protein, were affected also. These findings support the model that derangement of hippocampus signal transduction cascades in AD arises as a consequence of increased Aβ burden and chronic activation of the ERK MAPK cascade in an α7 nAChR-dependent manner that eventually leads to the downregulation of ERK2 MAPK and decreased phosphorylation of CREB protein.

Từ khóa


Tài liệu tham khảo

10.1001/archneur.56.6.673

10.1016/S0304-3940(99)00617-5

10.1016/0306-4522(85)90160-5

10.1038/2836

10.1523/JNEUROSCI.19-09-03535.1999

Borchelt, 1998, Inherited neurodegenerative diseases and transgenic models., Lab Anim Sci, 48, 604

10.1016/0092-8674(94)90400-6

10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X

10.1016/S0197-4580(97)00153-X

Burdick, 1992, Assembly and aggregation properties of synthetic Alzheimer's α4/β-amyloid peptide analogs., J Biol Chem, 267, 546, 10.1016/S0021-9258(18)48529-8

10.1038/6374

10.1016/S0140-6736(95)92053-6

10.1016/S0197-4580(96)00170-4

10.1523/JNEUROSCI.20-12-04563.2000

Dodart, 2000, The β-amyloid precursor protein and its derivatives: from biology to learning and memory processes., Rev Neurosci, 11, 75, 10.1515/REVNEURO.2000.11.2-3.75

10.1074/jbc.274.42.30322

10.1074/jbc.272.31.19103

10.1523/JNEUROSCI.19-12-04804.1999

10.1016/S0304-3940(00)01204-0

10.1523/JNEUROSCI.18-04-01187.1998

10.1016/0006-8993(88)90160-6

Freund, 1990, Nicotine interferes with GABA-mediated inhibitory processes in mouse hippocampus., Brain Res, 527, 286, 10.1016/0006-8993(90)91148-A

10.1074/jbc.272.34.21037

10.1523/JNEUROSCI.19-20-08876.1999

10.1016/S0531-5565(98)00045-X

10.1126/science.274.5284.99

10.1016/S0896-6273(00)80602-9

10.1097/00005072-199709000-00002

10.1523/JNEUROSCI.17-18-07053.1997

10.1002/ana.410420205

10.1111/j.1749-6632.1996.tb34409.x

10.1074/jbc.271.8.4077

10.1073/pnas.95.11.6448

Marks, 1983, Effects of chronic nicotine infusion on tolerance development and nicotinic receptors., J Pharmacol Exp Ther, 226, 817

10.1523/JNEUROSCI.19-08-02887.1999

10.1523/JNEUROSCI.17-24-09415.1997

10.1002/ana.410360616

10.1001/jama.283.12.1571

Nordberg, 1999, PET studies and cholinergic therapy in Alzheimer's disease., Rev Neurol (Paris), 155, S53

10.1046/j.1471-4159.2000.0742154.x

Payne, 1991, Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase)., EMBO J, 10, 885, 10.1002/j.1460-2075.1991.tb08021.x

10.1016/0306-4522(94)00410-7

10.1523/JNEUROSCI.21-01-j0003.2001

10.1046/j.1471-4159.2000.0740125.x

10.1038/353846a0

10.1074/jbc.271.48.30436

10.1523/JNEUROSCI.19-11-04337.1999

10.1111/j.1749-6632.1993.tb23023.x

Schafe, 1999, Memory consolidation for contextual and auditory fear conditioning is dependent on protein synthesis, PKA, and MAP kinase., Learn Mem, 6, 97, 10.1101/lm.6.2.97

Scheffel, 2000, 6-[18F]fluoro-A-85380: an in vivo tracer for the nicotinic acetylcholine receptor., Nucl Med Biol, 27, 51, 10.1016/S0969-8051(99)00082-7

10.1523/JNEUROSCI.13-02-00596.1993

10.1101/lm.6.5.478

10.1016/S0962-8924(98)01363-4

10.1016/0165-0270(91)90128-M

10.1038/334715a0

10.1016/S0304-3940(00)00767-9

10.1074/jbc.275.8.5626

10.1523/JNEUROSCI.20-16-05924.2000

10.1016/S0896-6273(00)81124-1

10.1126/science.273.5277.959

10.1038/382685a0

10.1006/nbdi.1999.0271